Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting ; volume:24 ; number:1 ; day:16 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (16.9.2024), 1-8, 12.2024
- Creator
-
Konishi, Keiji
Onozuka, Daisuke
Okubo, Moeka
Kasamatsu, Yu
Kutsuna, Satoshi
Shirano, Michinori
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-024-09904-x
- URN
-
urn:nbn:de:101:1-2411292059146.182401909781
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Konishi, Keiji
- Onozuka, Daisuke
- Okubo, Moeka
- Kasamatsu, Yu
- Kutsuna, Satoshi
- Shirano, Michinori
- SpringerLink (Online service)
Other Objects (12)
Long-Acting Reversible Contraception
Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Creation of a long-acting nanoformulated dolutegravir
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
Long-Acting Reversible Contraception
Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Creation of a long-acting nanoformulated dolutegravir
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
Long-Acting Reversible Contraception
Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Creation of a long-acting nanoformulated dolutegravir
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages